End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.4 TWD | +1.00% | +2.70% | +3.75% |
03-26 | Lukas Biomedical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lukas Biomedical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 185M 5.68M 7.75M | Sales 2023 | 232M 7.13M 9.72M | Capitalization | 1.08B 33.23M 45.32M |
---|---|---|---|---|---|
Net income 2022 | -50M -1.54M -2.1M | Net income 2023 | -47M -1.45M -1.97M | EV / Sales 2022 | 6.68 x |
Net Debt 2022 | 71.96M 2.21M 3.02M | Net Debt 2023 | 94.06M 2.89M 3.95M | EV / Sales 2023 | 5.07 x |
P/E ratio 2022 |
-23.1
x | P/E ratio 2023 |
-22.8
x | Employees | 88 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.92% |
1 day | +1.00% | ||
1 week | +2.70% | ||
Current month | +1.00% | ||
1 month | -0.33% | ||
3 months | +9.75% | ||
6 months | +12.18% | ||
Current year | +3.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chao An Liu
CEO | Chief Executive Officer | - | - |
Ying Min Liu
DFI | Director of Finance/CFO | - | - |
Chih Chao Tang
CHM | Chairman | - | 17-08-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wen Hsiu Chang
BRD | Director/Board Member | 67 | 20-12-11 |
Chi Ching Fu
BRD | Director/Board Member | - | 20-12-11 |
Chih Chao Tang
CHM | Chairman | - | 17-08-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-28 | 30.4 | +1.00% | 7 112 |
24-04-26 | 30.1 | +0.67% | 14,478 |
24-04-25 | 29.9 | +3.10% | 3,087 |
24-04-24 | 29 | -1.86% | 31,024 |
24-04-23 | 29.55 | +1.20% | 2,076 |
End-of-day quote Taipei Exchange, April 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.75% | 34.02M | |
-3.07% | 187B | |
-2.39% | 106B | |
-4.70% | 66.9B | |
+0.36% | 49.45B | |
+16.68% | 48B | |
+4.06% | 40.84B | |
+3.45% | 26.48B | |
+0.90% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 6814 Stock